KATIE GANN: Open Payments
NPI 1508154501 · HOUSTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,059 in 38 payments from 11 companies in 2025. Trend: 2023 $417 · 2024 $1,162 · 2025 $1,059
Food & beverage: $1,059
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 19 | $596 |
| Medtronic, Inc. | 4 | $102 |
| LeMaitre Vascular, Inc. | 3 | $61 |
| Abbott Laboratories | 2 | $50 |
| Dilon Technologies, Inc. | 2 | $45 |
| AtriCure, Inc. | 2 | $40 |
| Kerecis Limited | 2 | $40 |
| Artivion, Inc. | 1 | $38 |
| Boston Scientific Corporation | 1 | $37 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: COREVALVE EVOLUT R, NAVITOR, HEMOBLAST BELLOWS, Kerecis SurgiClose, XENOSURE BIOLOGIC PATCH, AMDS-Ascyrus Medical, ENROUTE Transcarotid Stent, KEYTRUDA.
Industry payments across MS — which companies pay providers there.
